Literature DB >> 2969023

Pneumocystis carinii pneumonia: therapy and prophylaxis.

J A Kovacs1, H Masur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969023     DOI: 10.1093/infdis/158.1.254

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  33 in total

1.  Efficacy and effects on pulmonary function tests of weekly 600 mg aerosol pentamidine as prophylaxis against Pneumocystis carinii pneumonia.

Authors:  E L Ong; E M Dunbar; B K Mandal
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 2.  Opportunistic protozoan infections in human immunodeficiency virus disease: review highlighting diagnostic and therapeutic aspects.

Authors:  A Curry; A J Turner; S Lucas
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 3.  Assessing HIV infection in primary care practice.

Authors:  H J Makadon
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

Review 4.  Pneumocystis carinii pneumonia.

Authors:  S Thomas; M O'Doherty; N Bateman
Journal:  BMJ       Date:  1990-01-27

5.  Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.

Authors:  B Ruf; I Rohde; H D Pohle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

6.  Optimization of in situ hybridization for detection of viral genomes in cultured cells on 96-microwell plates: a cytomegalovirus model.

Authors:  C Mougin; A Bassignot; A Coaquette; A Bourgeois; M Lab
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

7.  Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

Authors:  D M Schmatz; M A Romancheck; L A Pittarelli; R E Schwartz; R A Fromtling; K H Nollstadt; F L Vanmiddlesworth; K E Wilson; M J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Compliance and laboratory data predict relapse rate of Pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine.

Authors:  M Opravil; R Weber; B Ledergerber; R Speich; W Siegenthaler; R Lüthy
Journal:  Klin Wochenschr       Date:  1990-04-17

9.  Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs.

Authors:  M C Broughton; S F Queener
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 10.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.